<DOC>
	<DOCNO>NCT01531907</DOCNO>
	<brief_summary>This study design study difference bone turnover relation glucagon-like peptide-2 ( GLP-2 ) follow feed lean obese premenopausal woman . Given preliminary evidence GLP-2 may act directly osteoclast , investigator plan determine whether GLP2 receptor express osteoclast effect GLP-2 bone resorption . Hypotheses : 1 . Acute response GLP-2 bone resorption marker follow feeding affect body fat mass . 2 . Serum level GLP-2 low obese pre-menopausal woman associate reduction trabecular and/or cortical bone mass 3 . GLP-2 direct action osteoclast resorption via functional receptor</brief_summary>
	<brief_title>Relationships Between GLP-2 Markers Bone Turnover Following Feeding</brief_title>
	<detailed_description>Study objective : 1 . To determine difference baseline serum level GLP-2 related difference bone microarchitecture , structure strength distal tibia distal radius obese lean premenopausal female . 2 . To determine whether obesity premenopausal female influence level circulate GLP-2 follow standardise glucose meal resultant change marker bone formation resorption 3 . To test whether GLP-2 directly affect osteoclast function via identifiable receptor</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>Age 2540 Caucasian Premenopausal Able willing consent BMI either 18.524.9 kg/m2 â‰¥30 kg/m2 Completion 'The Effects Obesity Bone Structure Strength ' study REC ref 10/H1308/61 Consented approach future research study Fracture less twelve month prior recruitment History long term immobilization ( duration great three month ) Current pregnancy try conceive Pregnancy breast feeding le one year prior recruitment Diabetes mellitus History current condition know affect bone metabolism , may include : Diagnosed skeletal disease osteoarthritis Chronic renal disease Acute chronic hepatic disease Hyperparathyroidism Hyperthyroidism Malabsorption syndrome Diagnosed endocrine disorder Diagnosed diabetes mellitus Clinically significant hypocalcemia hypercalcemia Diagnosed restrictive eating disorder Current clinically significant previous use medication treatment know affect bone metabolism , example : Depot medroxyprogesterone combine oral contraceptive pill Glucocorticoid therapy Anticonvulsant therapy Bone treatment ( e.g . Bisphosphonates ) Alcohol intake great 21 unit per week Athlete , define individual participate competitive sport amateur professional level Monogenic obesity syndromes History cancer within past 5 year exclude skin cancer non melanoma</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>GLP2</keyword>
	<keyword>Obesity</keyword>
	<keyword>Premenopausal</keyword>
	<keyword>Bone</keyword>
	<keyword>Formation</keyword>
	<keyword>Resorption</keyword>
</DOC>